Early work showed elevated serum BAFF levels in patients with SSc, with BAFF mRNA expression up regulated in affected skin of patients with early diffuse cutaneous SSc and B cell BAFFR expression increased in SSc patients as compared to healthy controls (104). This evidence concerns the gene TNFRSF13C and systemic sclerosis.